Glutathione

Glutathione

Research peptide

Master antioxidant · liver and immunity

Early evidence
Molecule approved in ItalyWhat this means ›
🇮🇹 Italy · Approved🇺🇸 United States · Not approved

The molecule is approved as a medicine in Italy, under the brand TAD 600. TAD 600 is an injectable for hospital use. In the US it has no approval as a drug: it is prepared by compounding pharmacies. It is an antioxidant the body makes, studied as liver and skin support.

What is authorised is the Italian medicine for specific hospital uses, not the support uses under study. Our vial is research material (RUO).

Source: AIFA · TAD 600 (glutatión sódico), Biomedica Foscama

Overview

What has it been researched for?

  • Supports immunity Main focusEarly evidence
  • Reduces liver fatEarly evidence
  • Antioxidant: less oxidative stressEarly evidence
  • More even skin toneEarly evidence

Research protocols

The SBL research protocol and what the literature reports. Not medical advice.

SBL research protocol · no established clinical regimen in people

Dose
50 → 100 mg
Frequency
3×/semana
Duration
8 weeks
Route
Subcutaneous
Evidence level
Extrapolated

Tools

Evidence and studies

See studies →

Protocols

Research protocols

SBL research protocol · no established clinical regimen in people

Research use, with no established clinical regimen in people.

Dose
50 → 100 mg
Frequency
3×/semana
Timing
mañana
Duration
8 weeks
Break
No break
Route
Subcutaneous
Evidence level
Extrapolated

Example dose

05010025
25 u= 50 mg

100-unit U-100 insulin syringe · Starting dose of its protocol, with 3 ml of water in the 600 mg vial.

What it pairs with

  • GHK-Cu Alongside copper, at another time and in another syringe, it adds antioxidant support to the skin.

Preparation and dosing

Quick reference

Vial600 mg
Diluent3 ml
Concentration200 mg/ml
1 unit =2 mg

Preparation

Diluent
Bacteriostatic water

Open calculator →See the guide →

Evidence

Each effect with its evidence level and, where available, its source.

Strong evidence(0)Moderate evidence(0)Early evidence(4)
  • Supports immunityExtrapolatedSee study · 2018
  • Reduces liver fatExtrapolatedSee study · 2017
  • Antioxidant: less oxidative stressExtrapolatedSee study · 2015
  • More even skin toneExtrapolatedSee study · 2019

The science

Mechanisms, studies and references

Redox tripeptide

Safety

It makes sense if you want

  • Boost my immunity
  • Firmer, more radiant skin
  • Longevity & deep anti-aging

It does not make sense if

  • Active cancer or oncology treatment in the last 5 years
  • Pregnancy or breastfeeding
  • Severe liver impairment
  • Severe kidney impairment

Talk to your doctor first if this applies (2)

  • Liver disease
  • Kidney disease

The certificate of analysis (CoA) certifies the identity and purity of the batch. It does not certify safety of use.

Verify your batch →

For research use only (RUO). This consult is educational and does not replace your doctor.

Questions

Frequently asked questions

What is it reconstituted with, and how much?

With bacteriostatic water: 3 ml into the 600 mg vial, giving 200 mg/ml.

What is the starting dose of the research protocol?

50 → 100 mg, 3×/semana. This is the SBL research protocol, with no established clinical regimen in people.

How long is the cycle, and how long does a vial last?

8 weeks. At the starting dose, the 600 mg vial lasts ~2.3 sem.

Which route is used in research?

Subcutaneous.

When does it make no sense?

It makes no sense with: Active cancer or oncology treatment in the last 5 years, Pregnancy or breastfeeding, Severe liver impairment, Severe kidney impairment. Details in the Safety tab.

What is it combined with?

It goes well with GHK-Cu. The reasons are in the Protocols tab.

How do I check my batch?

With the code on the vial, in the verifier. The CoA certifies the identity and purity of the batch, not safety of use.

Verify your batch →

See kit

For research use only (RUO). This consult is educational and does not replace your doctor.